IP Library Granted Patent US 11,319,242
Granted Patent B2
US 11,319,242 · App. 16/473,246 · Granted May 3, 2022

Borosilicate glass with high chemical resistance and application thereof

Inventors: Weiqiang Hong (Dongguan, CN); Zhengshang Zhou (Dongguan, CN); Yong Jiang (Dongguan, CN); Lianying Zhu (Dongguan, CN); Xinqian He (Dongguan, CN); Hongxing Han (Dongguan, CN)
Assignee: Sunshine Lake Pharma Co., Ltd.
C03C3/095C03C4/20C03C13/001C03C13/002C04B14/44C03C2204/00C03C2213/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,319,242
App. No.
16/473,246
Granted
May 3, 2022
Kind
B2
Abstract

The invention discloses a borosilicate glass with high chemical resistance and an application thereof. The borosilicate glass contains 0.25-4.0 wt % of Y 2 O 3 based on the oxide. The borosilicate glass has a high chemical stability, a suitable linear thermal expansion coefficient and is suitable for use in the field of pharmaceutical packaging materials.

Claims (142)

1. A borosilicate glass comprising the following constituents based on oxide:

SiO 2

70-77

wt %,

B 2 O 3

9.0-12

wt %,

Al 2 O 3

3.0-7.0

wt %,

Na 2 O

5.0-8.0

wt %,

K 2 O

0-2.0

wt %,

Li 2 O

0-1.0

wt %,

wherein Σ(Na 2 O + K 2 O + Li 2 O)

5.0-8.0

wt %,

CaO

0-3.0

wt %,

MgO

0-1.0

wt %,

BaO

0-2.0

wt %,

wherein Σ(CaO + MgO + BaO)

0-5.0

wt %,

CeO 2

0-1.0

wt %,

NaCl

0-1.0

wt %,

Y 2 O 3

0.25-4.0

wt %.

2. The borosilicate glass of claim 1 comprising at least one of La 2 O 3 , ZrO 2 , and ZnO in a total amount from 0.49 to 4.0 wt %, wherein the content of each oxide is independently from 0 to 4.0 wt %.

3. The borosilicate glass of claim 1 comprising at least one of La 2 O 3 , ZrO 2 , and ZnO in a total amount from 0.49 to 3.0 wt %%, wherein the content of each oxide is independently from 0 to 3.0 wt %.

4. The borosilicate glass of claim 1 , wherein the borosilicate glass is free of As 2 O 3 and/or Sb 2 O 3 apart from inevitable impurities.

5. The borosilicate glass of claim 1 , having a coefficient of linear thermal expansion α20/300 from 4.6×10 −6 /K to 5.2×10 −6 /K, a class 1 water resistance according to YBB00362004-2015, a class 1 acid resistance according to YBB00342004-2015, and/or a class 1 alkali resistance according to YBB00352004-2015.

6. A process of using the borosilicate glass of claim 1 , wherein the glass is melted and formed into an article for a packaging material for a pharmaceutical, a container or a chemical device for a chemically erosive liquid, a sealing glass for an alloy or a glass fiber.

7. The process of claim 6 , wherein the glass fiber is for reinforcing concrete.

8. A borosilicate glass comprising the following constituents based on oxide:

SiO 2

70-76

wt %,

B 2 O 3

9.0-11.5

wt %,

Al 2 O 3

3.5-6.5

wt %,

Na 2 O

5.0-7.0

wt %,

K 2 O

0-1.0

wt %,

Li 2 O

0-1.0

wt %,

wherein Σ(Na 2 O + K 2 O + Li 2 O)

6.5-8.0

wt %,

CaO

0-2.0

wt %,

MgO

0-1.0

wt %,

BaO

0-1.5

wt %,

wherein Σ(CaO + MgO + BaO)

0-4.5

wt %,

CeO 2

0-0.5

wt %,

Y 2 O 3

0.5-3.5

wt %.

9. The borosilicate glass of claim 8 , comprising at least one of La 2 O 3 , ZrO 2 , and ZnO in a total amount from 0.49 to 4.0 wt %, wherein the content of each oxide is independently from 0 to 4.0 wt %.

10. The borosilicate glass of claim 8 , comprising at least one of La 2 O 3 , ZrO 2 , and ZnO in a total amount from 0.49 to 3.0 wt %, wherein the content of each oxide is independently from 0 to 3.0 wt %.

11. The borosilicate glass of claim 8 , wherein the borosilicate glass is free of As 2 O 3 and/or Sb 2 O 3 apart from inevitable impurities.

12. The borosilicate glass of claim 8 , having a coefficient of linear thermal expansion α 20/300 from 4.6×10 −6 /K to 5.2×10 −6 /K, a class 1 water resistance according to YBB00362004-2015, a class 1 acid resistance according to YBB00342004-2015, and/or a class 1 alkali resistance according to YBB00352004-2015.

13. A process of using the borosilicate glass of claim 8 , wherein the glass is melted and formed into an article for a packaging material for a pharmaceutical, a container or a chemical device for a chemically erosive liquid, a sealing glass for an alloy or a glass fiber.

14. A borosilicate glass comprising the following constituents based on oxide:

SiO 2

71-75.5

wt %,

B 2 O 3

9.1-11.0

wt %,

Al 2 O 3

3.8-6.5

wt %,

Na 2 O

5.5-7.0

wt %,

K 2 O

0-1.0

wt %,

Li 2 O

0-0.5

wt %,

wherein Σ(Na 2 O + K 2 O + Li 2 O)

6.0-8.0

wt %,

CaO

0-1.5

wt %,

MgO

0-0.5

wt %,

BaO

0.5-1.5

wt %,

wherein Σ(CaO + MgO + BaO)

0.5-3.5

wt %,

CeO 2

0-1.0

wt %,

NaCl

0-1.0

wt %,

Y 2 O 3

0.5-3.0

wt %.

15. The borosilicate glass of claim 14 , comprising at least one of La 2 O 3 , ZrO 2 , and ZnO in a total amount from 0.49 to 4.0 wt %, wherein the content of each oxide is independently from 0 to 4.0 wt %.

16. The borosilicate glass of claim 14 , comprising at least one of La 2 O 3 , ZrO 2 , and ZnO in a total amount from 0.49 to 3.0 wt %, wherein the content of each oxide is independently from 0 to 3.0 wt %.

17. The borosilicate glass of claim 14 , wherein the borosilicate glass is free of As 2 O 3 and/or Sb 2 O 3 apart from inevitable impurities.

18. The borosilicate glass of claim 14 , having a coefficient of linear thermal expansion α 20/300 from 4.6×10 −6 /K to 5.2×10 −6 /K, a class 1 water resistance according to YBB00362004-2015, a class 1 acid resistance according to YBB00342004-2015, and/or a class 1 alkali resistance according to YBB00352004-2015.

19. A process of using the borosilicate glass of claim 14 , wherein the glass is melted and formed into an article for a packaging material for a pharmaceutical, a container or a chemical device for a chemically erosive liquid, a sealing glass for an alloy or a glass fiber.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2024
From: SUNSHINE LAKE PHARMA CO., LTD.
To: RUYUAN HEC PHARMACEUTICAL GLASS TECHNOLOGY CO., LTD.
Reel/Frame 069222/0988 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2020
From: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
To: SUNSHINE LAKE PHARMA CO., LTD.
Reel/Frame 052871/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2019
From: SUNSHINE LAKE PHARMA CO., LTD.; NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
To: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
Reel/Frame 050945/0839 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2019
From: HONG, WEIQIANG; ZHOU, ZHENGSHANG; JIANG, YONG; ZHU, LIANYING; HE, XINQIAN; HAN, HONGXING
To: SUNSHINE LAKE PHARMA CO., LTD.
Reel/Frame 049572/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2019
From: SUNSHINE LAKE PHARMA CO., LTD.
To: SUNSHINE LAKE PHARMA CO., LTD.; NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
Reel/Frame 049572/0670 →
Priority Claims (1)
CN 201611241380.3 · Dec 29, 2016 · national
Continuity (1)
Related Publication 20190322569A1 · Oct 24, 2019